Logo image
Transforming Growth Factor Beta (TGF-beta) Signaling in Head and Neck Squamous Cell Carcinoma (HNSCC)
Book chapter

Transforming Growth Factor Beta (TGF-beta) Signaling in Head and Neck Squamous Cell Carcinoma (HNSCC)

Alexander E. Kudinov and Tim N. Beck
Molecular Determinants of Head and Neck Cancer
01 Jan 2018

Abstract

Biochemistry & Molecular Biology Life Sciences & Biomedicine Oncology Science & Technology
Transforming growth factor receptor beta (TGF-beta) signaling is commonly dysregulated in head and neck squamous cell carcinoma (HNSCC). TGF-beta signaling influences homeostasis in normal epithelial cells and regulates a critical signaling network during development. In HNSCC, TGF-beta signaling frequently promotes cell invasion, metastasis, proliferation, and drug resistance and may present an important therapeutic target. Canonical TGF-beta signaling generally involves activation of SMAD effector proteins, most prominently SMAD2 and SMAD3, whereas noncanonical TGF-beta signaling requires signal propagators including ERK, AKT, and RAF, also commonly employed by receptor tyrosine kinases (RTKs), thereby providing opportunities for signaling crosstalk. Several members of the TGF-beta superfamily are being explored as potential targets to control drug resistance and metastatic spread, both important barriers to cure in HNSCC. In this chapter, the roles of TGF-beta in HNSCC are described, with particular focus on molecular signaling, TGF-beta's role in controlling gene expression, and relevant therapeutic directions involving TGF-beta.

Metrics

12 Record Views
2 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Biochemistry & Molecular Biology
Oncology
Logo image